Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Histology01:27

Liver Histology

4.5K
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
4.5K
Liver Physiology01:30

Liver Physiology

3.9K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.9K
Liver Regeneration01:24

Liver Regeneration

4.5K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.5K
Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

2.1K
The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
2.1K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

211
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
211

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonlinear Association Between Metabolic Syndrome Severity and Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastro hep advances·2026
Same author

OCE-205, a selective V1a receptor mixed agonist-antagonist, for the treatment of hepatorenal syndrome-acute kidney injury: A phase 2 randomized trial.

Hepatology (Baltimore, Md.)·2026
Same author

Impacts of Neighborhood Persistent Poverty and Socioeconomic Status on Hepatocellular Carcinoma Outcomes: A Large Population-Based Cohort Study.

Cancer medicine·2026
Same author

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.

Gut·2026
Same author

Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis.

Scientific reports·2025
Same author

Submit to Pearls From the Pros.

Gastro hep advances·2025
Same journal

Beyond allocation: What multi-listing reveals about equity in transplant access.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Meeting the demand: Incorporating living donor liver transplantation into the deceased donor liver transplantation landscape.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

From empiricism to personalized therapy: Is there still a role for prophylactic antifibrinolytics in liver transplantation?

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Multimodal deep learning using pre-transplant CT images predicts cardiovascular events after liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Post-transplant management.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Development of multicenter consensus care plans for immunosuppression after pediatric liver transplant: Reducing variability, creating comparative efficacy opportunities.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

9.0K

Microbiota and the liver.

Ting-Chin David Shen1, Nikolaos Pyrsopoulos2, Vinod K Rustgi3

  • 1Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|January 10, 2018
PubMed
Summary
This summary is machine-generated.

The gut microbiome significantly impacts liver health, with imbalances linked to various liver diseases like NAFLD and ALD. Understanding this connection is crucial for managing liver conditions.

More Related Videos

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K
Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice
04:29

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice

Published on: September 19, 2019

6.8K

Related Experiment Videos

Last Updated: Feb 15, 2026

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

9.0K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K
Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice
04:29

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice

Published on: September 19, 2019

6.8K

Area of Science:

  • Gastroenterology and Hepatology
  • Microbiology
  • Immunology

Background:

  • The human gut microbiome, vastly outnumbering the human genome, is integral to host metabolism, immune function, and pathogen defense.
  • Gut dysbiosis, an imbalance in microbial communities, is increasingly implicated in the pathogenesis of liver diseases.
  • Specific liver conditions such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and alcoholic liver disease (ALD) show associations with gut microbiome alterations.

Purpose of the Study:

  • To provide a comprehensive overview of the intricate relationship between the gut microbiome and liver diseases.
  • To highlight the role of microbial dysbiosis in the development and progression of various hepatic conditions.
  • To synthesize current understanding regarding the gut-liver axis in health and disease.

Main Methods:

  • Literature review and synthesis of existing research on gut microbiome and liver disease.
  • Analysis of studies investigating microbial composition, function, and host interactions in liver disease models and patients.
  • Examination of evidence linking dysbiosis to NAFLD, NASH, ALD, cirrhosis, and their complications.

Main Results:

  • The gut microbiome influences liver physiology through metabolic, immune, and protective mechanisms.
  • Dysbiosis is a common feature across a spectrum of liver diseases, including NAFLD, NASH, and ALD.
  • Alterations in gut bacteria contribute to liver inflammation, fibrosis, and disease progression.

Conclusions:

  • The gut microbiome is a critical factor in liver health and disease.
  • Targeting the gut microbiome presents a potential therapeutic strategy for liver diseases.
  • Further research into the gut-liver axis is warranted to elucidate mechanisms and develop novel interventions.